Should Meridia Remain On Market? FDA Says 'Yes'-For Now At Least-European Drug Regulators Say 'No'

Should Meridia Remain On Market? FDA Says 'Yes' (For Now At Least), European Drug Regulators Say 'No' Difference Of Opinion Suggests There Could Be A Possible Meridia Recall In U.S. Before The FDA Holds Its Public Advisory Meeting In September 2010 http://www.drug-injury.com/druginjurycom/2010/01/meridia-sibutramine-suspension-of-sales-europe-risks-outweigh-benefits-fda-considers-possible-recall.html
Contributor
Wilmington, North Carolina
Personal Injury
About
I have a national litigation practice based in Wilmington, North Carolina, representing people who have cases involving prescription drug injury lawsuits and asbestos-mesothelioma claims.